A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer - Trial NCT06379412
Access comprehensive clinical trial information for NCT06379412 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhujiang Hospital and is currently Recruiting. The study focuses on Colorectal Cancer. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zhujiang Hospital
Timeline & Enrollment
N/A
Jul 01, 2023
Dec 01, 2024
Primary Outcome
HPLC-MS/MS was used to detect peptidoglycan fragment content in biological specimens of 200 participants
Summary
The goal of this observational study is to explore the association of peptidoglycan fragments
 derived from gut microbiota with colorectal cancer (CRC). The main question it aims to answer
 is: Are peptidoglycan fragments from the gut microbiota associated with the progression of
 colorectal cancer? Participants will provide biological specimens (blood, feces, colon tissue
 obtained during surgery)
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06379412
Non-Device Trial